Research Article

Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study

Table 5

Mean values of concentrations of measured urinary analytes normalized to urinary creatinine for patients with IgAN and disease controls.

AnalyteIgAN Disease controls

Metabolomic markers
 Malondialdehyde (ng/mg)6.36.2
 4-Hydroxyhexenal (ng/mg)5.95.5
 4-Hydroxynonenal (ng/mg)6.67.2
 Hexanal (ng/mg)5.54.6
 Heptanal (ng/mg)6.25.6
 Oktanal (ng/mg)3.02.6
 Nonanal (ng/mg)2.92.9
 Decanal (ng/mg)2.72.4
 Undodecanal (ng/mg)1.41.3
 8-Hydroxyguanosine (pg/mg)65.654.6
 5-Hydroxymethyluracil (pg/mg)32.630.2
 o-Tyrosine (pg/mg)18.116.0
 3-Chlorotyrosine (pg/mg)10.08.6
 Leukotriene B4 (pg/mg)75.856.1
 8-Isoprostane (pg/mg)8.47.4
 Leukotriene E4 (pg/mg)26.024.5
 Leukotriene D4 (pg/mg)12.412.3
 Leukotriene C4 (pg/mg)14.514.0
Proteomic markers
 Interleukin 6 (pg/mg)22.416.0
 Interleukin 8 (pg/mg)20.111.5
 Monocyte chemotactic protein-1 (ng/mg)1.10.9
 EGF (ng/mg)0.50.6
α1-Antitrypsin (ng/mg) 10.87.8
 IgA-Uromodulin (ng/mg)99.140.3
 Galactose-deficient IgA1 (ng/mg)35.528.1
 Soluble transferrin receptor (ng/mg)7.87.1
 LG3 fragment of endorepellin (ng/mg)9.812.3
 Tumstatin (pg/mg)30.631.9
 Endostatin (pg/mg)36.435.7
Heparan sulfate (μg/mg)0.40.2